Northrop Grumman (NYSE:NOC) Misses Q1 Sales Targets, Stock Drops

Security and aerospace company Northrop Grumman (NYSE:NOC) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.6% year on year to $9.47 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $42.25 billion at the midpoint. Its GAAP profit of $3.32 per share was 46.7% below analysts’ consensus estimates.

Is now the time to buy Northrop Grumman? Find out in our full research report .

Northrop Grumman (NOC) Q1 CY2025 Highlights:

Company Overview

Responsible for the development of the first stealth bomber, Northrop Grumman (NYSE:NOC) specializes in providing aerospace, defense, and security solutions for various industry applications.

Defense Contractors

Defense contractors typically require technical expertise and government clearance. Companies in this sector can also enjoy long-term contracts with government bodies, leading to more predictable revenues. Combined, these factors create high barriers to entry and can lead to limited competition. Lately, geopolitical tensions–whether it be Russia’s invasion of Ukraine or China’s aggression towards Taiwan–highlight the need for defense spending. On the other hand, demand for these products can ebb and flow with defense budgets and even who is president, as different administrations can have vastly different ideas of how to allocate federal funds.

Sales Growth

A company’s long-term sales performance is one signal of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last five years, Northrop Grumman grew its sales at a sluggish 3.3% compounded annual growth rate. This fell short of our benchmark for the industrials sector and is a tough starting point for our analysis.

Northrop Grumman (NYSE:NOC) Misses Q1 Sales Targets, Stock Drops

We at StockStory place the most emphasis on long-term growth, but within industrials, a half-decade historical view may miss cycles, industry trends, or a company capitalizing on catalysts such as a new contract win or a successful product line. Northrop Grumman’s annualized revenue growth of 4.3% over the last two years aligns with its five-year trend, suggesting its demand was consistently weak.

OK